Co-Authors
This is a "connection" page, showing publications co-authored by Claire Andrejak and Jean-Philippe Lanoix.
Connection Strength
0.289
-
Association between renin-angiotensin system inhibitors and COVID-19 complications. Eur Heart J Cardiovasc Pharmacother. 2021 09 21; 7(5):426-434.
Score: 0.061
-
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
Score: 0.059
-
The association between body mass index class and coronavirus disease 2019 outcomes. Int J Obes (Lond). 2021 03; 45(3):700-705.
Score: 0.057
-
Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes. Diabetes Metab Res Rev. 2021 03; 37(3):e3388.
Score: 0.056
-
Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID-19. Br J Clin Pharmacol. 2021 03; 87(3):1547-1553.
Score: 0.056